Get started
Author

Cornelis Van Arkel

SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer
2015 · Christian Eichelberg, Walter L. Vervenne, et al. · European Urology · 139
PDF
SWITCH: A randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC).
2014 · Maurice Stephan Michel, Walter Vervenne, et al. · Journal of Clinical Oncology · 44
Micro-electrophoresis of mucopolysaccharides on agarose gel
1963 · C. van Arkel, R.E. Ballieux, et al. · Journal of Chromatography A · 13
Subgroup analyses of a randomized sequential open-label study (SWITCH) to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC).
2014 · Peter J. Goebell, Walter Vervenne, et al. · Journal of Clinical Oncology · 12
Thrombosis and bleeding disorders. Theory and methods
1972 · C. van Arkel · European Journal of Obstetrics & Gynecology and Reproductive Biology · 12
Tenfold Increased Incidence of Spontaneous Multiple Myeloma in Long-Term Immunosuppressed Aging C57BL/KaLwRij Mice
1996 · Jiri Radl, Cornelis van Arkel, et al. · Clinical Immunology and Immunopathology · 11
PDF
Micro‐electrophoresis of Heparin
1963 · L. B. Jacques, R. E. Ballieux, et al. · Acta Medica Scandinavica · 11
Phase III randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO) followed by sunitinib (SU) versus sunitinib followed by sorafenib in patients with advanced/metastatic renal cell carcinoma without prior systemic therapy (SWITCH Study): Safety interim analysis results.
2012 · Maurice Stephan Michel, Walter Vervenne, et al. · Journal of Clinical Oncology · 10
Blood Coagulation as a Continuous Process
1960 · J. Roos, C. van Arkel, et al. · Acta Medica Scandinavica · 8
Resolution of EBV+ CNS lymphoma with appearance of CSF EBV‐specific T cells
2005 · Janet W. de Beukelaar, Cornelis van Arkel, et al. · Annals of Neurology · 6
Monoclonal gammopathies in aging μ, x‐transgenic mice: Involvement of the B‐1 cell lineage
1997 · Cornelis van Arkel, Cornelis M. Hopstaken, et al. · European Journal of Immunology · 6
Activation of coagulation, stasis and the amniotic fluid embolism syndrome
1971 · L.A.M. Stolte, H.T. Lim, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 6
Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)
2014 · C. Eichelberg, P.J. Goebell, et al. · Annals of Oncology · 5
Frequency of Clonal Dominance in the Specific Antibody Response to DNP-HSA in CBA and C57BL Mice Reflects Their Susceptibility to Age-Associated Development of Monoclonal Gammopathies
1997 · Cornelis van Arkel, Frans J.M. Nooij, et al. · Clinical Immunology and Immunopathology · 5
Amniotic fluid, fetal urine and clot-promoting activity
1972 · M.J. Kool, L.A.M. Stolte, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 3
Pathogenetic Aspects of Monoclonal Gammopathies: a study in aging mice
1998 · C. van Arkel · EUR Research Repository (Erasmus University Rotterdam)
Works count: 18
Citation count: 291
H-index: 8
I10-index: 8
Year
Topic
Type